Table 2 Predicted value of Corporate Health Impact Assessment
From: Assessing the health impact of transnational corporations: its importance and a framework
Predicted value to researchers |
Evidence to inform public policy decisions |
Evidence elucidating the health and health equity impacts of individual TNCs’ structures, products and practices; and how these differ between countries |
Understanding of how TNC practices affecting health are influenced by international and national regulatory structures |
Predicted value to civil society activists |
Advocacy tool to enhance community capacity to understand and engage on issues associated with health impact of TNC operations |
Facilitate community involvement in debates about TNC health impact and possible government response |
Predicted value to corporations |
Evidence to inform corporate policies and practices to reduce adverse and optimise positive impacts on health and health equity within their countries of operation; and to achieve greater equity of practices across countries |
Predicted value to governments and policy-makers |
Evidence to inform policy decisions regarding project approval and appropriate regulation |